Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.
about
Cancer of the Pancreas: Molecular Pathways and Current Advancement in TreatmentDeciphering the role of hedgehog signaling in pancreatic cancerPancreatic cancer from bench to bedside: molecular pathways and treatment optionsCurrent concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemKRAS Mutant Pancreatic Cancer: No Lone Path to an Effective TreatmentGenetics and biology of pancreatic ductal adenocarcinomaNoncoding RNAs and pancreatic cancerViro-immune therapy: A new strategy for treatment of pancreatic cancerDevelopmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular OriginRecent advances in the molecular diagnostics of gastric cancerPerspectives in the treatment of pancreatic adenocarcinomaPancreatic adenocarcinoma pathology: changing "landscape"Evolution and dynamics of pancreatic cancer progressionInherited pancreatic cancer syndromesGenetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencingImmune checkpoint and inflammation as therapeutic targets in pancreatic carcinomaPancreatic Cancer, A Mis-interpreter of the Epigenetic LanguageNonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunopreventionA Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the PancreasThe Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear StructureAnti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algaeInterleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistanceIdentification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell LinesNovel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma.Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer.MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls.Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells.Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation.Pathology and molecular genetics of pancreatic neoplasms.Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients.Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancer.Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous NeoplasmMAPK signaling is required for dedifferentiation of acinar cells and development of pancreatic intraepithelial neoplasia in mice.Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions.Oncogenic KRAS signalling in pancreatic cancer.CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer.The transcription factor GLI1 modulates the inflammatory response during pancreatic tissue remodeling
P2860
Q26740619-1EFBDF15-3D5E-4136-B723-29CC99807E70Q26747103-F42F7129-721F-47D6-B136-07BAF86D7B44Q26747524-640AFF3D-73AE-49EF-8CCB-985CB0F19A24Q26748510-62FF73D4-B094-42E2-8D3D-07F6998EDEE6Q26751520-3F9CABD6-1B44-4217-AF03-90792FCE41D6Q26765438-3583A73A-B629-44F0-8543-1F5EF7D9C1D8Q26774630-E8A37D45-3280-403C-869E-EB74DAB90581Q26774641-096310DF-2F3A-46FF-AE3E-4EA0A9584603Q26774942-6DE7DB68-EA29-4595-87A7-128AEE924ACFQ26785548-5FAB722A-6789-45C6-A3CD-1BB714F09A2AQ26797248-09853932-FCDE-4D4B-A5CF-E76CFC162FB6Q26799446-C1400ACF-291F-4867-9A9C-5FBF950E14AAQ26849671-D0944BF1-E25E-4360-8CF2-99940537C171Q26853530-1A46C694-B702-42F2-A80F-EA114F1922D5Q26991615-009A7A65-1CA4-4ED1-A43C-7AFF91A85DA2Q28069864-B70AC042-611A-43D2-A475-F3DC512DD62BQ28079735-1F29BED8-47C2-4C6D-9237-2167E05AE4F3Q28082487-1094B29B-0B3C-4E60-A3F1-BDEF0C6F0990Q28082890-0E00E34F-B52D-478A-8523-0A089556C3CCQ28084785-1DE8F830-7B85-42B0-9231-CF951EFA10C7Q28486199-6A3F058A-812D-49D5-898E-C05F89BE95D9Q28504893-DC69770D-E939-4537-AF2F-90A950EA821DQ28553394-4B13A0D0-8297-4295-AB8B-75AB020A4592Q30235129-EE2D14FF-1FB2-496F-81A3-00FB0C0AE75CQ30313606-DD2EF33A-517C-44AA-BB8D-DD30974DAC52Q30541314-EA63E9E7-DB36-4490-9DDB-C3B7BF781359Q30841369-A6E459EB-D8AE-48E4-BB82-B056C87C0052Q31162502-4D80A745-AD00-4F18-BDBA-73D2B8B7E555Q33581119-EBE56697-799F-4FDE-8079-F4AEAA891ACBQ33582635-43E1475C-931C-4B70-98BC-8BCD8CCDD927Q33591508-9B09A545-2A0A-410B-B01B-4001FC4359A6Q33624574-BF708042-7848-40A3-9ABD-0271A9467089Q33635144-75ACF72E-8AA8-46B1-8733-E9F62E88CD1CQ33680759-D560507F-20F4-473B-A3DE-616F1A5E282DQ33838679-DC92ABDA-A052-4B44-8187-899D62CE1769Q33858586-FEC57711-B2CA-4EC1-A514-7473F8C9BAAEQ33891283-97DDAA58-1333-4907-AA3B-4B355BAF588EQ34113460-CC06F30D-8B3A-45FE-89E9-630F7394511FQ34227791-BBB85703-FFF2-46BC-A73E-6E6736287865Q34283489-4FE9BF22-7AF9-419E-B683-A0D0FEF302A6
P2860
Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.
@en
type
label
Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.
@en
prefLabel
Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.
@en
P2093
P2860
P50
P1433
P1476
Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.
@en
P2093
Hanno Matthaei
Michael Borges
Mitsuro Kanda
P2860
P304
730-733.e9
P356
10.1053/J.GASTRO.2011.12.042
P407
P577
2012-01-05T00:00:00Z